Norway· NO-ID_0AFBF2B3-BF3F-4C52-AD5D-7FB8B7C5ADA0
Paxlovid
A nirmatrelvir und ritonavir product containing nirmatrelvir + ritonavir, registered in Norway by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nirmatrelvir und ritonavir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AE30 (nirmatrelvir und ritonavir), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Nirmatrelvir und ritonavir · ATC J05AE30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of nirmatrelvir und ritonavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nirmatrelvir und ritonavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$851.25
The record
At a glance
FEST (Norway)- Active substance
- Nirmatrelvir + Ritonavir
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Norway (NO)
- ATC code
- J05AE30
- ATC class
- Nirmatrelvir und Ritonavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_0AFBF2B3-BF3F-4C52-AD5D-7FB8B7C5ADA0
- no_varenummer59148820NOK 13162.5
- gtin5415062384794
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for nirmatrelvir und ritonavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nirmatrelvir und ritonavir · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Nirmatrelvir und ritonavir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAXLOVIDPfizer Europe MA EEIG, Bruxelles
- CanadaPAXLOVIDPFIZER CANADA ULC
- SpainPAXLOVID 150 MG + 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- FinlandPaxlovidPfizer Europe MA EEIG
- FrancePAXLOVID 150 mg + 100 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- IcelandPaxlovidPfizer Europe MA EEIG*
- NetherlandsPaxlovid 150 mg filmomhulde tabletten (PF-12345678) en 100 mg filmomhulde tabletten (ritonavir)Pfizer Europe MA EEIG
- PolandPaxlovidPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Paxlovid
- Liechtenstein · Paxlovid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5753d0f1-7ed9-4a02-a70d-630ea4bcb187 GET /v1/drugs/5753d0f1-7ed9-4a02-a70d-630ea4bcb187?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Nirmatrelvir og ritonavir",
"merkevare_id": "ID_0AFBF2B3-BF3F-4C52-AD5D-7FB8B7C5ADA0",
"name_form_strength": "Paxlovid tab 150 mg",
"prescription_group": "C"
}See everything about nirmatrelvir und ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.